Pages that link to "Q42188961"
Jump to navigation
Jump to search
The following pages link to A formalin-inactivated whole SIV vaccine confers protection in macaques (Q42188961):
Displaying 50 items.
- Pathogenesis of human immunodeficiency virus infection (Q24634681) (← links)
- HIV-1 prophylactic vaccines: state of the art (Q26740042) (← links)
- Application of radiation technology in vaccines development (Q26798165) (← links)
- A brief history of the global effort to develop a preventive HIV vaccine (Q26851165) (← links)
- The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaques (Q27305204) (← links)
- Vaccination with a live retrovirus: the nature of the protective immune response (Q28335614) (← links)
- Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials (Q28394899) (← links)
- Survivors Remorse: antibody-mediated protection against HIV-1. (Q30238730) (← links)
- Human immunodeficiency virus vaccine an update (Q30432382) (← links)
- Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates (Q30831495) (← links)
- Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV (Q33395672) (← links)
- HIV vaccines. (Q33591503) (← links)
- Inactivation of respiratory syncytial virus by zinc finger reactive compounds. (Q33663190) (← links)
- Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections (Q33784692) (← links)
- Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. (Q33784777) (← links)
- Evidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain. (Q33802066) (← links)
- Enhanced binding of antibodies to neutralization epitopes following thermal and chemical inactivation of human immunodeficiency virus type 1. (Q33806303) (← links)
- Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex (Q33822379) (← links)
- CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing (Q33835440) (← links)
- Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates (Q33933855) (← links)
- Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus (Q33937698) (← links)
- Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope (Q33984221) (← links)
- Assessment of HIV vaccine development: past, present, and future (Q34050712) (← links)
- Microdevices for examining immunological responses of single cells to HIV (Q34065197) (← links)
- Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160 (Q34171623) (← links)
- Duesberg, HIV and AIDS. (Q34188786) (← links)
- A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease (Q34228507) (← links)
- Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection (Q34348640) (← links)
- Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection (Q34358162) (← links)
- The ethical conduct of clinical trials of HIV vaccines (Q34412044) (← links)
- Challenges in the development of an HIV-1 vaccine (Q34657290) (← links)
- Strategies for an HIV vaccine (Q34717847) (← links)
- HIV-1 vaccines: the search continues (Q34876150) (← links)
- Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS (Q35097510) (← links)
- HIV vaccines 1983-2003. (Q35166836) (← links)
- Survey of human-use adjuvants (Q35192171) (← links)
- Immunological Adjuvants (Q35210796) (← links)
- HIV vaccine research: the challenge and the way forward (Q35227007) (← links)
- DNA vaccines against human immunodeficiency virus type 1 in the past decade (Q35745831) (← links)
- Formalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III. (Q35818688) (← links)
- Effects of U-75875, a peptidomimetic inhibitor of retroviral proteases, on simian immunodeficiency virus infection in rhesus monkeys (Q35821454) (← links)
- Syphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits (Q35830294) (← links)
- Liver disease in rhesus monkeys infected with simian immunodeficiency virus (Q35831199) (← links)
- Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. (Q35839114) (← links)
- Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5) (Q35848231) (← links)
- Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies (Q35854001) (← links)
- Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine (Q35857571) (← links)
- Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon. (Q35858637) (← links)
- Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection (Q35871792) (← links)
- Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques (Q35876182) (← links)